Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study

The aim of this study was to compare the irinotecan/cisplatin regimen with cisplatin as second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC) pretreated with a taxane/gemcitabine regimen. Patients (n=147) with stage IV NSCLC pretreated with a taxane/gemcitabine regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgoulias, V, Agelidou, A, Syrigos, K, Rapti, A, Agelidou, M, Nikolakopoulos, J, Polyzos, A, Athanasiadis, A, Tselepatiotis, E, Androulakis, N, Kalbakis, K, Samonis, G, Mavroudis, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361638/
https://www.ncbi.nlm.nih.gov/pubmed/16175189
http://dx.doi.org/10.1038/sj.bjc.6602748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361638/
https://www.ncbi.nlm.nih.gov/pubmed/16175189
http://dx.doi.org/10.1038/sj.bjc.6602748

Ejemplares similares